yingweiwo

Others 12

Others 12

Others 12 related products

Structure Cat No. Product Name CAS No. Product Description
Lenalidomide-C10-OH V58435 Lenalidomide-C10-OH 2503018-12-8 Lenalidomide-C10-OH (6a) is an intermediate in the preparation /synthesis of INY-03-041.
Levetiracetam-d6 (ring-d6) (UCB L059-d6 (ring-d6)) V61651 Levetiracetam-d6 (ring-d6) (UCB L059-d6 (ring-d6)) 1133229-30-7 Levetiracetam-d6 (ring-d6) can be used as an internal standard for the determination of Levetiracetam content in whole blood.
Lexanersen (WVE-120102) V70387 Lexanersen (WVE-120102) 2073015-40-2 Lexanersen (WVE-120102) is an oligonucleotide useful in Huntington's disease study.
Lexanersen sodium (WVE-120102 sodium) V70382 Lexanersen sodium (WVE-120102 sodium) 2223673-42-3 Lexanersen sodium is an oligonucleotide useful in Huntington's disease study.
LI-2242 V58844 LI-2242 2762762-17-2 LI-2242 is an inhibitor (blocker/antagonist) of phytate kinase (IP6K).
LIN28 inhibitor LI71 enantiomer V62249 LIN28 inhibitor LI71 enantiomer 956189-58-5 LIN28 inhibitor LI71 enantiomer is the less active enantiomer of LIN28 inhibitor LI71.
Linaprazan glurate (X842) V62484 Linaprazan glurate (X842) 1228559-81-6 Linaprazan glurate inhibits exogenously or endogenously stimulated gastric acid secretion.
Linoleamide (Linoleic acid amide) V56871 Linoleamide (Linoleic acid amide) 3999-01-7 Linoleamide is a linoleic acid amide.
Lipase Substrate V60236 Lipase Substrate 195833-46-6 Lipase Substrate may be utilized to detect lipase activity.
Lithium citrate (lithium citrate; Litarex) V59568 Lithium citrate (lithium citrate; Litarex) 919-16-4 Lithium citrate reduces excess N-acetyl aspartate in the brain in Canavan disease.
LM2I V57945 LM2I 2055494-50-1 LM2I is an analogue of spinosad (SPA).
LMP7-IN-2 V61664 LMP7-IN-2 1613317-24-0 LMP7-IN-2 is an LMP7 inhibitor useful in the treatment of related inflammatory diseases and disorders.
LNnDFH I (Lacto-N-neo-difucohexaose I) V58546 LNnDFH I (Lacto-N-neo-difucohexaose I) 62469-99-2 LNnDFH I is a naturally occurring compound that can be extracted from human urine.
LNP Lipid-8 V62287 LNP Lipid-8 2408140-60-1 LNP Lipid-8 (11-AM) is an ionizable lipid that works as a lipid nanoparticle (LNP) to deliver siRNA to T cells without targeting ligands.
Locostatin (UIC-1005) V64350 Locostatin (UIC-1005) 90719-30-5 Locostatin (UIC-1005) is a potent RKIP inhibitor.
Lomardexamfetamine (KP 106) V61500 Lomardexamfetamine (KP 106) 1032291-80-7 Lomardexamfetamine (KP 106) is an orally bioactive central nervous system/CNS activator consisting of d-amphetamine and a ligand.
Lometraline hydrochloride V59687 Lometraline hydrochloride 30060-91-4 Lometraline HCl is an aminotetralin analogue used in Parkinson's disease (PD) research.
Lonazolac V57576 Lonazolac 53808-88-1 Lonazolac is a nonsteroidal antirheumatic agent.
LONP1-IN-2 V64356 LONP1-IN-2 2729981-17-1 LONP1-IN-2 (compound 9d) is a potent and specific LONP1 inhibitor (antagonist) with IC50s of 0.187 μM and >10 μM for LONP1 and 20S proteasome, respectively.
LP-184 V62265 LP-184 924835-67-6 LP-184 (compound 6), an acyl fluoroethylene analog, inhibits tumor growth.
Contact Us